- ORCID iD
-
0009-0007-4871-7843
Show
Sort by
-
TRIPLE-TARGET BLOCKADE OF CHI3L1, LCN2 AND PD-L1 REDUCES TUMOR GROWTH AND ENHANCES IMMUNOSTIMULATION IN A MOUSE TNBC MODEL
(2026) -
Targeting chitinase-like proteins to overcome immune checkpoint blockade resistance in heterogeneous triple-negative mammary tumors
(2026) -
Neutrophil-derived chitinase 3-like 1 drives immunosuppression in triple-negative breast cancer : insights from a CHI3L1 knockout mouse model
-
- Journal Article
- A1
- open access
Tractable mouse TNBC models capture the heterogeneous tumor immune microenvironment and adaptation to PD-L1 blockade
-
Transcriptomic adaptation of the cold versus hot triple-negative breast tumor immune microenvironment to PD-L1 blockade
-
Transcriptomic heterogeneity of nine complementary mouse TNBC models based on their comparative in vitro and in vivo characterization
-
Lipocalin-2 blockade enhances anti-PD-1 efficacy in an immunosuppressed mouse TNBC model
-
Comparative profiling of mouse TNBC models with differential TME states that mimic clinical heterogeneity
-
Chitin-mediated blockade of chitinase-like proteins reduces tumor growth and immunosuppression in a mouse model for TNBC
-
Lipocalin-2 blockade reduces tumor growth and neutrophil infiltration in a mouse model for TNBC